Relay Therapeutics, Inc. (RLAY)
NGM · Common · CUSIP 75943R102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RLAY and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
75943R102
IPO
7/16/2020 · $20.00/share
Business: Relay Therapeutics, Inc. is a clinical-stage precision medicines company transforming the drug discovery process with the goal of bringing life-changing therapies to patients. Built on unparalleled insights into protein motion and how this dynamic behavior relates to protein function, Relay Therapeutics aims to effectively drug protein targets that have previously been intractable, with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology.

Company Contact

CEO
Sanjiv K. Patel
VPF
Tom Catinazzo
Headquarters
399 Binney Street, 2nd Floor, Cambridge, MA 02139
Phone
617-370-8837
Investor Relations
Pete Rahmer · 617-370-8837 · prahmer@relaytx.com
SEC EDGAR Filings
View filings »